Koyfin Home > Directory > Health Care > Revance Therapeutics > Market Cap

Revance Therapeutics Market Cap Chart (RVNC)

Revance Therapeutics annual/quarterly Market Cap from 2014 to 2020. Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
  • Revance Therapeutics Market Cap for the quarter ending September 09, 2020 was $1,696m a -6.65% decrease of -113m year over year
  • Revance Therapeutics Market Cap for the last 12 months ending September 09, 2020 was $1,696m a -6.65% decrease of -113m year over year
  • Revance Therapeutics Annual Market Cap for 2020 was $1,696m a 0.00% decrease of 0m from 2019
  • Revance Therapeutics Annual Market Cap for 2020 was $1,696m a -2.91% decrease of -49m from 2019
  • Revance Therapeutics Annual Market Cap for 2020 was $1,746m a -3.63% decrease of -63m from 2019
Other Valuation Metrics:
  • Revance Therapeutics Price / Book for the quarter ending March 03, 2018 was 4.18 a -6.42% decrease of -0.27 year over year
  • Revance Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $850m a 27.67% increase of 235m year over year
View Chart On Koyfin

Quarterly RVNC Market Cap Data

09/2020$1,696m
09/2020$1,696m
09/2020$1,746m
09/2020$1,809m
09/2020$1,911m
09/2020$2,106m
09/2020$2,117m
09/2020$2,261m
09/2020$2,206m
09/2020$1,936m

Annual RVNC Market Cap Data

2020$1,696m
2020$1,696m
2020$1,746m
2020$1,809m
2020$1,911m
2020$2,106m
2020$2,117m
2020$2,261m
2020$2,206m
2020$1,936m